FDA Panel Rejects Use of MDMA for Treatment of PTSDAn independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.
Source: FDA Panel Rejects Use of MDMA for Treatment of PTSD (https://www.nytimes.com/2024/06/04/health/fda-mdma-therapy-ptsd.html)